Skip to main content
. Author manuscript; available in PMC: 2023 Jan 24.
Published in final edited form as: Contemp Clin Trials. 2016 Jul 19;50:45–53. doi: 10.1016/j.cct.2016.07.017

Table 3.

Selected baseline characteristics of the intent to treat sample.

Total sample
(N = 183)
Integrated condition
(N = 95)
Sequential condition
(N = 88)
Test statistic P-value
Age, years: M(SD) 44.1(13.0) 44.4 (13.1) 43.8 (13.0) t(181) = 0.35 0.73
Sex, N (%) male 169 (92.3) 90 (94.7) 79 (89.8) χ2 = 1.59 0.207
Race, N (%) White 75 (41.0) 37(38.9) 38(43.2) χ2 = 0.34 0.561
Ethnicity, N (%) Hispanic or Latino 9 (4.9) 7(7.4) 2(2.3) χ2 = 2.54 0.111
Marital status, N (%) married 67 (36.6) 44(46.3) 23(26.1) χ2 = 8.02 0.005
PTSD Checklist (PCL) 63.0 (10.9) 62.5(11.3) 63.6(10.3) t(181) = −0.66 0.513
% days heavy drinking 53.8 (29.6) 51.7(29.5) 56.0(29.6) t(181) = −0.99 0.325
PTSD Symptom Scale Interview (PSS-I) 36.4 (6.6) 35.8(6.9) 36.9(6.4) t(181) = −1.12 0.263
Patient Health Questionnaire (PHQ-9) 15.4 (5.7) 14.7(5.8) 16.1(5.5) t(181) = −1.75 0.083
Medical Outcomes Study Short Form (SF-12) mental component 29.2 (9.7) 30.9(9.4) 27.3(9.8) t(181) = 2.52 0.013
Medical Outcomes Study Short Form (SF-12) physical component 45.3 (7.8) 45.3(7.6) 45.2(8.0) t(181) = 0.05 0.96
Short Inventory of Problems (SIP-R)a 17.9 (10.7) 16.4(10.6) 19.5(10.6) t(180) = −2 0.047

PTSD = posttraumatic stress disorder.

a

n = 182 for this variable.